科隆再注气研究:DMEK术后624次再注气的重新评估
该回顾性队列研究分析了德国科隆大学医院1541例DMEK中499只接受再注气眼的移植片脱离特征、再注气对术后12个月结局的影响及对侧眼再注气风险。结果显示再注气次数与时机不影响BSCVA、CCT、ECD及内皮细胞丢失,但一眼再注气者对侧眼再注气率显著升高(58.8% vs 32.3%,p=0.000)。
要点
- 再注气次数与时机不影响DMEK术后12个月的视力、角膜厚度及内皮细胞密度。
- 移植片脱离面积平均2.02±0.9处,横向直径4534.76±1920.83 μm,轴向382.53±282.02 μm,分布均匀。
- 一眼需再注气者对侧眼再注气风险显著升高(58.8% vs 32.3%,p=0.000)。
核心结论
- 再注气次数不影响DMEK术后结局,但一眼再注气提示对侧眼再注气风险升高。
研究设计与样本
- 回顾性队列研究,纳入1541例DMEK中499只于德国科隆大学医院接受再注气的眼,分析OCT扫描与临床记录。
主要发现
- 移植片脱离平均2.02±0.9处,横向直径4534.76±1920.83 μm,轴向382.53±282.02 μm,均匀分布于角膜各区域。
- 术后12个月BSCVA为0.197±0.23 logMAR,ECD为1575.21±397.71 cells/mm2,CCT为566.37±68.11 μm。
- 再注气次数及DMEK与再注气间隔时间均不影响BSCVA、CCT、ECD或内皮细胞丢失。
- 再注气患者中对侧眼后续行DMEK者有193只(58.8%)也接受再注气,显著高于总体再注气率32.3%(p=0.000)。
关键数值与推荐
- 再注气患者总体再注气率为32.3%。
- 对侧眼再注气率为58.8%,与总体率比较p=0.000。
- 术后12个月BSCVA 0.197±0.23 logMAR,ECD 1575.21±397.71 cells/mm2,CCT 566.37±68.11 μm。
临床怎么用
- 再注气次数与时机不影响术后结局,临床决策不必因次数而顾虑。
- 一眼再注气后应警惕对侧眼再注气风险升高,加强随访。
局限性
- 为单中心回顾性研究,仅纳入接受再注气的眼,未报告未再注气对照的详细比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: To analyse graft detachments prior to rebubbling, the influence of rebubbling on the postoperative outcome after Descemet membrane endothelial keratoplasty (DMEK) and the need for rebubbling on the contralateral eye. METHODS: In this retrospective cohort study, out of 1541 DMEKs, optical coherence tomography scans and clinical records of 499 eyes undergoing rebubbling after DMEK at the University Hospital of Cologne, Cologne, Germany, were examined. Main Outcome measures were (a) number, localisation and size of graft detachments; (b) influence of rebubbling/s on postoperative outcome after 12 months; and (c) rebubbling risk of the contralateral eye after DMEK. RESULTS: Mean number of detachment areas was 2.02±0.9. Mean lateral diameter of all detachments was 4534.76±1920.83 μm. Mean axial diameter was 382.53±282.02 μm. Detachments were equally distributed over all regions of the cornea. Best spectacle corrected visual acuity ( BSCVA) after 12 months was 0.197±0.23 logarithm of the minimum angle of resolution, endothelial cell density (ECD) was 1575.21±397.71 cells/mm2 and mean central corneal thickness (CCT) was 566.37±68.11 μm. BSCVA, CCT, ECD or endothelial cell loss of all rebubbled patients were not influenced by the number of rebubblings or the time between DMEK and rebubbling. Of the rebubbled patients, which received a DMEK subsequently on the other eye, 193 (58.8%) also received a rebubbling, which was significantly higher, when compared to the overall rebubbling rate of 32.3% (p=0.000). CONCLUSIONS: The overall number of rebubblings has no influence on the postoperative outcome after DMEK, if a rebubbling becomes necessary. Patients who received a rebubbling on one eye have an elevated risk for a rebubbling on the fellow eye.
引用
- Siebelmann S, Kolb K, Scholz P, et al. The Cologne rebubbling study: a reappraisal of 624 rebubblings after Descemet membrane endothelial keratoplasty. Br J Ophthalmol. 2020. PMID: 32816807. doi:10.1136/bjophthalmol-2020-316478
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。